Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03807648 · ClinicalTrials.gov registry record
I USE LR in the ED
A clinical trial of Kidney Injury, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 200,000
- Enrollment target
- 1
- Study location
NCT03807648 is a study of Kidney Injury that has completed, run by Intermountain Health Care. The registered enrollment target is 200,000 participants, above the 307-participant average among 9 other Kidney Injury trials with a reported enrollment target (65047% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03807648, a study of Kidney Injury, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 200,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.
Conditions Studied
Interventions
- OTHER Data Inclusion
Study Locations (1)
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2020-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03807648
The ClinicalTrials.gov registry entry for NCT03807648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 307-participant average among 9 other Kidney Injury trials with a reported enrollment target (65047% higher). The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Data Inclusion is the first listed.
NCT03807648 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT03807648 about?
NCT03807648 is a clinical study titled "I USE LR in the ED". To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.
What is the current status of trial NCT03807648?
This trial is currently completed. The enrollment target is 200,000 participants. The study started on 2018-12-20. Estimated completion is 2020-01-31.
What conditions does trial NCT03807648 study?
This clinical trial studies the following conditions: Kidney Injury.
What interventions are being tested in trial NCT03807648?
The interventions under investigation include: Data Inclusion (OTHER).
Who is sponsoring clinical trial NCT03807648?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03807648 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
RECRUITING · Phase 4
-
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RECRUITING
-
KIDney Injury in Times of COVID-19 (KIDCOV)
RECRUITING
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
ACTIVE NOT RECRUITING · NA
-
Renal Considerations in the Heat Stress Recommendations (Aim2)
COMPLETED · NA
-
Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.